Editor Note- Journal of Regenerative Biology and Medicine Volume 3 Issue 2
Journal Title: Journal of Regenerative Biology and Medicine - Year 2021, Vol 3, Issue 2
Abstract
As a Vascular Surgeon with more than 18 years of experience, I have been dealing, as most of my colleagues, with maybe the most demanding vascular condition, the Peripheral Arterial Disease (PAD). The increasing development of surgical techniques, especially in the endovascular field, and the continuous arrival of new tools in our operating rooms, allow us today to treat patients that until a few years ago we would have considered without any surgical option.
Authors and Affiliations
Ottorino Del Foco*
Keywords
Related Articles
- EP ID EP707367
- DOI https://doi.org/10.37191/Mapsci-2582-385X-3(2)-063
- Views 70
- Downloads 0
Anti-inflammatory and Antifibrotic Effects of Plant Regulatory Peptides in Patients with Steatohepatitis and Cirrhosis: Opportunities of Primary Liver Cancer Prevention
The pathogenesis of steatohepatitis, which develops on the background of non-alcoholic fatty liver disease and may be the cause of liver cirrhosis, is considered in the article. Also, the paper focuses on the prospects o...
Allogenic Human Umbilical Cord Derived Mesenchymal Stem Cells for Managing Knee Osteoarthritis in Human - A Clinical Trial
Introduction: Human Mesenchymal Stem Cell has been scientifically accepted as a method of managing Osteoarthritis in the Human knee. They can be derived from Autologous Bone Marrow, Adipose Tissue, and less commonly Syno...
Short Review on the Advancement of Osteoarthritis Treatment with Cell Therapy
Osteoarthritis has huge impact on medical care system and finance as its large patient populations and its increasing contribution to the chronic disability in age population. Increasing effort to develop new treatment o...
Foetal Healing Cascade - Can We Duplicate it in Adults?
The scientific study of medicine is all about the science of healing. Whether the focus be on the mind or body, the fascination with prolonging life, improving the quality of life, and generating new life is a theme that...
Treatment Options in COVID-19: The Role of Bioavailable Antiviral Ribonucleoside Analog on NHC in Vitro
On December 31, 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on January 7, 2020 and was provisionally named "2...